{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:56:42Z","timestamp":1789016202949,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Since February 2020, exception points have been allocated equivalent to the median model for end-stage liver disease at transplant within 250 nautical miles of the transplant center (MMaT\/250). We compared transplant rate and waitlist mortality for hepatocellular carcinoma (HCC) exception, non-HCC exception, and non-exception candidates to determine whether MMaT\/250 advantages (or disadvantages) exception candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Using Scientific Registry of Transplant Recipients data, we identified 23\u2005686 adult, first-time, active, deceased donor liver transplant (DDLT) candidates between February 4, 2020, and February 3, 2022. We compared DDLT rates using Cox regression, and waitlist mortality\/dropout using competing risks regression in non-exception versus HCC versus non-HCC candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Within 24 mo of study entry, 58.4% of non-exception candidates received DDLT, compared with 57.8% for HCC candidates and 70.5% for non-HCC candidates. After adjustment, HCC candidates had 27% lower DDLT rate (adjusted hazard ratio\u2005=\u2005\n                      <jats:sub>0.68<\/jats:sub>\n                      0.73\n                      <jats:sub>0.77<\/jats:sub>\n                      ) compared with non-exception candidates. However, waitlist mortality for HCC was comparable to non-exception candidates (adjusted subhazard ratio [asHR]\u2005=\u2005\n                      <jats:sub>0.93<\/jats:sub>\n                      1.03\n                      <jats:sub>1.15<\/jats:sub>\n                      ). Non-HCC candidates with pulmonary complications of cirrhosis or cholangiocarcinoma had substantially higher risk of waitlist mortality compared with non-exception candidates (asHR\u2005=\u2005\n                      <jats:sub>1.27<\/jats:sub>\n                      1.70\n                      <jats:sub>2.29<\/jats:sub>\n                      for pulmonary complications of cirrhosis,\n                      <jats:sub>1.35<\/jats:sub>\n                      2.04\n                      <jats:sub>3.07<\/jats:sub>\n                      for cholangiocarcinoma). The same was not true of non-HCC candidates with exceptions for other reasons (asHR\u2005=\u2005\n                      <jats:sub>0.54<\/jats:sub>\n                      0.88\n                      <jats:sub>1.44<\/jats:sub>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Under MMaT\/250, HCC, and non-exception candidates have comparable risks of dying before receiving liver transplant, despite lower transplant rates for HCC. However, non-HCC candidates with pulmonary complications of cirrhosis or cholangiocarcinoma have substantially higher risk of dying before receiving liver transplant; these candidates may merit increased allocation priority.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000004957","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:53Z","timestamp":1711670453000},"page":"e170-e180","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)\/250-mile Policy"],"prefix":"10.1097","volume":"108","author":[{"given":"Tanveen","family":"Ishaque","sequence":"first","affiliation":[{"name":"Department of Surgery, New York University Langone Transplant Institute, New York, NY."},{"name":"Department of Surgery, New York University Grossman School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Beckett","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sommer","family":"Gentry","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University Langone Transplant Institute, New York, NY."},{"name":"Department of Surgery, New York University Grossman School of Medicine, New York, NY."},{"name":"Scientific Registry of Transplant Recipients, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Garonzik-Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Karhadkar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie E.","family":"Lonze","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University Langone Transplant Institute, New York, NY."},{"name":"Department of Surgery, New York University Grossman School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim J.","family":"Halazun","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University Langone Transplant Institute, New York, NY."},{"name":"Department of Surgery, New York University Grossman School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry","family":"Segev","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University Langone Transplant Institute, New York, NY."},{"name":"Department of Surgery, New York University Grossman School of Medicine, New York, NY."},{"name":"Scientific Registry of Transplant Recipients, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan B.","family":"Massie","sequence":"additional","affiliation":[{"name":"Department of Surgery, New York University Langone Transplant Institute, New York, NY."},{"name":"Department of Surgery, New York University Grossman School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1600-6143.2010.03127.x","article-title":"Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system.","volume":"10","author":"Washburn","year":"2010","journal-title":"Am J Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/lt.23394","article-title":"Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.","volume":"18","author":"Goldberg","year":"2012","journal-title":"Liver Transpl"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1600-6143.2011.03735.x","article-title":"MELD exceptions and rates of waiting list outcomes.","volume":"11","author":"Massie","year":"2011","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ajt.15144","article-title":"Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.","volume":"19","author":"Ishaque","year":"2019","journal-title":"Am J Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5662\/wjm.v12.i1.32","article-title":"Liver transplant allocation policies and outcomes in United States: a comprehensive review.","volume":"12","author":"Latt","year":"2022","journal-title":"World J Methodol"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/lt.26368","article-title":"The impact of median model for end-stage liver disease at transplant minus 3 national policy on waitlist outcomes in patients with and without hepatocellular carcinoma.","volume":"28","author":"Bernards","year":"2022","journal-title":"Liver Transpl"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.15149","article-title":"The national landscape of deceased donor kidney transplantation for the highly sensitized: transplant rates, waitlist mortality, and posttransplant survival under KAS.","volume":"19","author":"Jackson","year":"2019","journal-title":"Am J Transplant"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2015080934","article-title":"Early changes in kidney distribution under the new allocation system.","volume":"27","author":"Massie","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/ajt.14622","article-title":"Geographic disparity in kidney transplantation under KAS.","volume":"18","author":"Zhou","year":"2018","journal-title":"Am J Transplant"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation.","volume":"16","author":"Stewart","year":"2016","journal-title":"Am J Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/lt.26509","article-title":"Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States.","volume":"28","author":"Shah","year":"2022","journal-title":"Liver Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.12777","article-title":"Big data in organ transplantation: registries and administrative claims.","volume":"14","author":"Massie","year":"2014","journal-title":"Am J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios.","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biostatistics\/kxn014","article-title":"Effective communication of standard errors and confidence intervals.","volume":"10","author":"Louis","year":"2009","journal-title":"Biostatistics"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/TP.0000000000002643","article-title":"Geographic disparity in deceased donor liver transplant rates following share 35.","volume":"103","author":"Bowring","year":"2019","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lt.25807","article-title":"Comparison of wait-list mortality between cholangiocarcinoma and hepatocellular carcinoma liver transplant candidates.","volume":"26","author":"Ziogas","year":"2020","journal-title":"Liver Transpl"},{"issue":"suppl 3","key":"R21-20250604","first-page":"361","article-title":"MELD exception score: LSAM modeling of a fixed floor.","volume":"17","author":"Heimbach","year":"2017","journal-title":"Am J Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/lt.26286","article-title":"The effect of acuity circles on deceased donor transplant and offer rates across model for end-stage liver disease scores and exception statuses.","volume":"28","author":"Wey","year":"2022","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"R23-20250604","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 annual data report: liver.","volume":"21","author":"Kwong","year":"2021","journal-title":"Am J Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cld.545","article-title":"Model for end-stage liver disease exception points for treatment-responsive hepatocellular carcinoma.","volume":"7","author":"Parikh","year":"2016","journal-title":"Clin Liver Dis"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/lt.24098","article-title":"MELDEQ: an alternative model for end-stage liver disease score for patients with hepatocellular carcinoma.","volume":"21","author":"Marvin","year":"2015","journal-title":"Liver Transpl"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/tri.12967","article-title":"Comparison of two equivalent model for end-stage liver disease scores for hepatocellular carcinoma patients using data from the United Network for Organ Sharing liver transplant waiting list registry.","volume":"30","author":"Alver","year":"2017","journal-title":"Transpl Int"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/ajt.16373","article-title":"Liver transplantation in the United States during the COVID-19 pandemic: national and center-level responses.","volume":"21","author":"Strauss","year":"2021","journal-title":"Am J Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1111\/ajt.16167","article-title":"Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic.","volume":"20","author":"Boyarsky","year":"2020","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:03:32Z","timestamp":1749045812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004957","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}